Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Key value for chemical safety assessment

Skin sensitisation

Link to relevant study records

Referenceopen allclose all

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
weight of evidence
Reliability:
2 (reliable with restrictions)
Justification for type of information:
Read across valid as the substnace tested is also titanate complex with alkylphosphate, degrading in water to form simple alcohols including 2-propanol and phosphate esters.
Reason / purpose for cross-reference:
read-across source
Species:
guinea pig
Strain:
Dunkin-Hartley
Sex:
female
Route:
other: intradermal injections and topical applications
Vehicle:
other: 5% v/v Acetone in Alembicol D for intradermal injection and as supplied for topical application.
Concentration / amount:
Concentration of test material and vehicle used at induction:
a) 0.5% v/v in acetone containing 5% w/v alembicol D
b) Undiluted

Concentration of test material and vehicle used for each challenge:
20% and 50% v/v in acetone
Route:
other: topical applications
Vehicle:
other: 5% v/v Acetone in Alembicol D for intradermal injection and as supplied for topical application.
Concentration / amount:
Concentration of test material and vehicle used at induction:
a) 0.5% v/v in acetone containing 5% w/v alembicol D
b) Undiluted

Concentration of test material and vehicle used for each challenge:
20% and 50% v/v in acetone
No. of animals per dose:
Number of animals in test group: 20
Number of animals in negative control group: 20
Challenge controls:
Two weeks after induction, test and control animals were challenged topically with test substance at 50% and 20% v/v in acetone. Patches were applied for 24 hours and sites were evaluated 24, 48 and 72 hours after removal.
Reading:
1st reading
Hours after challenge:
72
Group:
test chemical
Dose level:
50% v/v in acetone
No. with + reactions:
3
Total no. in group:
20
Clinical observations:
Positive evidence of delayed contact hypersensitivity
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 72.0. Group: test group. Dose level: 50% v/v in acetone. No with. + reactions: 3.0. Total no. in groups: 20.0. Clinical observations: Positive evidence of delayed contact hypersensitivity.
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
50% v/v in acetone
No. with + reactions:
2
Total no. in group:
20
Clinical observations:
Erythema (barely perceptible) - localised dermal reaction
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 50% v/v in acetone. No with. + reactions: 2.0. Total no. in groups: 20.0. Clinical observations: Erythema (barely perceptible) - localised dermal reaction.
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
50% v/v in acetone
No. with + reactions:
8
Total no. in group:
20
Clinical observations:
Erythema (barely perceptible)
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 50% v/v in acetone. No with. + reactions: 8.0. Total no. in groups: 20.0. Clinical observations: Erythema (barely perceptible).
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
50% v/v in acetone
No. with + reactions:
3
Total no. in group:
20
Clinical observations:
Oedema (barely perceptible)
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 50% v/v in acetone. No with. + reactions: 3.0. Total no. in groups: 20.0. Clinical observations: Oedema (barely perceptible).
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
20% v/v in acetone
No. with + reactions:
3
Total no. in group:
20
Clinical observations:
Erythema (barely perceptible) - localised dermal reaction
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 20% v/v in acetone. No with. + reactions: 3.0. Total no. in groups: 20.0. Clinical observations: Erythema (barely perceptible) - localised dermal reaction.
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
20% v/v acetone
No. with + reactions:
2
Total no. in group:
20
Clinical observations:
Erythema (barely perceptible)
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 20% v/v acetone. No with. + reactions: 2.0. Total no. in groups: 20.0. Clinical observations: Erythema (barely perceptible).
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
20% v/v acetone
No. with + reactions:
1
Total no. in group:
20
Clinical observations:
Oedema (barely perceptible)
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 20% v/v acetone. No with. + reactions: 1.0. Total no. in groups: 20.0. Clinical observations: Oedema (barely perceptible).
Reading:
1st reading
Hours after challenge:
48
Group:
test chemical
Dose level:
50% v/v in acetone
No. with + reactions:
3
Total no. in group:
20
Clinical observations:
Erythema (well defined) - dryness and sloughing of the epidermis observed
Remarks on result:
other: see Remark
Remarks:
Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 50% v/v in acetone. No with. + reactions: 3.0. Total no. in groups: 20.0. Clinical observations: Erythema (well defined) - dryness and sloughing of the epidermis observed.
Reading:
1st reading
Hours after challenge:
48
Group:
test chemical
Dose level:
50% v/v in acetone
No. with + reactions:
4
Total no. in group:
20
Clinical observations:
Erythema (barely perceptible) - localised dermal reaction
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 50% v/v in acetone. No with. + reactions: 4.0. Total no. in groups: 20.0. Clinical observations: Erythema (barely perceptible) - localised dermal reaction.
Reading:
1st reading
Hours after challenge:
48
Group:
test chemical
Dose level:
50% v/v in acetone
No. with + reactions:
1
Total no. in group:
20
Clinical observations:
Erythema (barely perceptible)
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 50% v/v in acetone. No with. + reactions: 1.0. Total no. in groups: 20.0. Clinical observations: Erythema (barely perceptible).
Reading:
1st reading
Hours after challenge:
48
Group:
test chemical
Dose level:
50% v/v in acetone
No. with + reactions:
3
Total no. in group:
20
Clinical observations:
Oedema (barely perceptible)
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 50% v/v in acetone. No with. + reactions: 3.0. Total no. in groups: 20.0. Clinical observations: Oedema (barely perceptible).
Reading:
1st reading
Hours after challenge:
48
Group:
test chemical
Dose level:
20% v/v in acetone
No. with + reactions:
1
Total no. in group:
20
Clinical observations:
Erythema (barely perceptible) - localised dermal reaction
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 20% v/v in acetone. No with. + reactions: 1.0. Total no. in groups: 20.0. Clinical observations: Erythema (barely perceptible) - localised dermal reaction.
Reading:
1st reading
Hours after challenge:
48
Group:
test chemical
Dose level:
20% v/v in acetone
No. with + reactions:
1
Total no. in group:
20
Clinical observations:
Erythema (well defined) - dryness and sloughing of the epidermis observed
Remarks on result:
other: see Remark
Remarks:
Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 20% v/v in acetone. No with. + reactions: 1.0. Total no. in groups: 20.0. Clinical observations: Erythema (well defined) - dryness and sloughing of the epidermis observed.
Reading:
1st reading
Hours after challenge:
48
Group:
test chemical
Dose level:
20% v/v in acetone
No. with + reactions:
1
Total no. in group:
20
Clinical observations:
Erythema (barely perceptible) - dryness and sloughing of the epidermis observed
Remarks on result:
other: see Remark
Remarks:
Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 20% v/v in acetone. No with. + reactions: 1.0. Total no. in groups: 20.0. Clinical observations: Erythema (barely perceptible) - dryness and sloughing of the epidermis observed.
Reading:
1st reading
Hours after challenge:
48
Group:
test chemical
Dose level:
20% v/v in acetone
No. with + reactions:
1
Total no. in group:
20
Clinical observations:
Oedema (barely perceptible)
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 20% v/v in acetone. No with. + reactions: 1.0. Total no. in groups: 20.0. Clinical observations: Oedema (barely perceptible).
Reading:
1st reading
Hours after challenge:
72
Group:
test chemical
Dose level:
50% v/v in acetone
No. with + reactions:
2
Total no. in group:
20
Clinical observations:
Erythema (barely perceptible) - dryness and sloughing of the epidermis observed
Remarks on result:
other: see Remark
Remarks:
Reading: 1st reading. . Hours after challenge: 72.0. Group: test group. Dose level: 50% v/v in acetone. No with. + reactions: 2.0. Total no. in groups: 20.0. Clinical observations: Erythema (barely perceptible) - dryness and sloughing of the epidermis observed.
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
50% v/v in acetone
No. with + reactions:
2
Total no. in group:
20
Clinical observations:
Erythema (barely perceptible)
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 50% v/v in acetone. No with. + reactions: 2.0. Total no. in groups: 20.0. Clinical observations: Erythema (barely perceptible).
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
50% v/v in acetone
No. with + reactions:
2
Total no. in group:
20
Clinical observations:
Erythema (barely perceptible) - localised dermal reaction
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 50% v/v in acetone. No with. + reactions: 2.0. Total no. in groups: 20.0. Clinical observations: Erythema (barely perceptible) - localised dermal reaction.
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
20% v/v in acetone
No. with + reactions:
2
Total no. in group:
20
Clinical observations:
Erythema (barely perceptible) - localised dermal reaction
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 20% v/v in acetone. No with. + reactions: 2.0. Total no. in groups: 20.0. Clinical observations: Erythema (barely perceptible) - localised dermal reaction.

Evidence of sensitisation of each challenge concentration:
Evidence of sensitisation was observed in 3 animals.

Interpretation of results:
GHS criteria not met
Conclusions:
The target substance is concluded to be not sensitising to skin, based on studies read across from sturctural analogue.
Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Qualifier:
according to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Deviations:
no
GLP compliance:
yes
Type of study:
guinea pig maximisation test
Justification for non-LLNA method:
Available existing study.
Species:
guinea pig
Strain:
Dunkin-Hartley
Sex:
female
Route:
other: intradermal injections and topical applications
Vehicle:
other: 5% v/v Acetone in Alembicol D for intradermal injection and as supplied for topical application.
Concentration / amount:
Concentration of test material and vehicle used at induction:
a) 0.5% v/v in acetone containing 5% w/v alembicol D
b) Undiluted

Concentration of test material and vehicle used for each challenge:
20% and 50% v/v in acetone
Route:
other: topical applications
Vehicle:
other: 5% v/v Acetone in Alembicol D for intradermal injection and as supplied for topical application.
Concentration / amount:
Concentration of test material and vehicle used at induction:
a) 0.5% v/v in acetone containing 5% w/v alembicol D
b) Undiluted

Concentration of test material and vehicle used for each challenge:
20% and 50% v/v in acetone
No. of animals per dose:
Number of animals in test group: 20
Number of animals in negative control group: 20
Challenge controls:
Two weeks after induction, test and control animals were challenged topically with test substance at 50% and 20% v/v in acetone. Patches were applied for 24 hours and sites were evaluated 24, 48 and 72 hours after removal.
Positive control substance(s):
no
Reading:
1st reading
Hours after challenge:
72
Group:
test chemical
Dose level:
50% v/v in acetone
No. with + reactions:
3
Total no. in group:
20
Clinical observations:
Positive evidence of delayed contact hypersensitivity
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 72.0. Group: test group. Dose level: 50% v/v in acetone. No with. + reactions: 3.0. Total no. in groups: 20.0. Clinical observations: Positive evidence of delayed contact hypersensitivity.
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
50% v/v in acetone
No. with + reactions:
2
Total no. in group:
20
Clinical observations:
Erythema (barely perceptible) - localised dermal reaction
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 50% v/v in acetone. No with. + reactions: 2.0. Total no. in groups: 20.0. Clinical observations: Erythema (barely perceptible) - localised dermal reaction.
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
50% v/v in acetone
No. with + reactions:
8
Total no. in group:
20
Clinical observations:
Erythema (barely perceptible)
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 50% v/v in acetone. No with. + reactions: 8.0. Total no. in groups: 20.0. Clinical observations: Erythema (barely perceptible).
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
50% v/v in acetone
No. with + reactions:
3
Total no. in group:
20
Clinical observations:
Oedema (barely perceptible)
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 50% v/v in acetone. No with. + reactions: 3.0. Total no. in groups: 20.0. Clinical observations: Oedema (barely perceptible).
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
20% v/v in acetone
No. with + reactions:
3
Total no. in group:
20
Clinical observations:
Erythema (barely perceptible) - localised dermal reaction
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 20% v/v in acetone. No with. + reactions: 3.0. Total no. in groups: 20.0. Clinical observations: Erythema (barely perceptible) - localised dermal reaction.
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
20% v/v acetone
No. with + reactions:
2
Total no. in group:
20
Clinical observations:
Erythema (barely perceptible)
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 20% v/v acetone. No with. + reactions: 2.0. Total no. in groups: 20.0. Clinical observations: Erythema (barely perceptible).
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
20% v/v acetone
No. with + reactions:
1
Total no. in group:
20
Clinical observations:
Oedema (barely perceptible)
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 20% v/v acetone. No with. + reactions: 1.0. Total no. in groups: 20.0. Clinical observations: Oedema (barely perceptible).
Reading:
1st reading
Hours after challenge:
48
Group:
test chemical
Dose level:
50% v/v in acetone
No. with + reactions:
3
Total no. in group:
20
Clinical observations:
Erythema (well defined) - dryness and sloughing of the epidermis observed
Remarks on result:
other: see Remark
Remarks:
Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 50% v/v in acetone. No with. + reactions: 3.0. Total no. in groups: 20.0. Clinical observations: Erythema (well defined) - dryness and sloughing of the epidermis observed.
Reading:
1st reading
Hours after challenge:
48
Group:
test chemical
Dose level:
50% v/v in acetone
No. with + reactions:
4
Total no. in group:
20
Clinical observations:
Erythema (barely perceptible) - localised dermal reaction
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 50% v/v in acetone. No with. + reactions: 4.0. Total no. in groups: 20.0. Clinical observations: Erythema (barely perceptible) - localised dermal reaction.
Reading:
1st reading
Hours after challenge:
48
Group:
test chemical
Dose level:
50% v/v in acetone
No. with + reactions:
1
Total no. in group:
20
Clinical observations:
Erythema (barely perceptible)
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 50% v/v in acetone. No with. + reactions: 1.0. Total no. in groups: 20.0. Clinical observations: Erythema (barely perceptible).
Reading:
1st reading
Hours after challenge:
48
Group:
test chemical
Dose level:
50% v/v in acetone
No. with + reactions:
3
Total no. in group:
20
Clinical observations:
Oedema (barely perceptible)
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 50% v/v in acetone. No with. + reactions: 3.0. Total no. in groups: 20.0. Clinical observations: Oedema (barely perceptible).
Reading:
1st reading
Hours after challenge:
48
Group:
test chemical
Dose level:
20% v/v in acetone
No. with + reactions:
1
Total no. in group:
20
Clinical observations:
Erythema (barely perceptible) - localised dermal reaction
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 20% v/v in acetone. No with. + reactions: 1.0. Total no. in groups: 20.0. Clinical observations: Erythema (barely perceptible) - localised dermal reaction.
Reading:
1st reading
Hours after challenge:
48
Group:
test chemical
Dose level:
20% v/v in acetone
No. with + reactions:
1
Total no. in group:
20
Clinical observations:
Erythema (well defined) - dryness and sloughing of the epidermis observed
Remarks on result:
other: see Remark
Remarks:
Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 20% v/v in acetone. No with. + reactions: 1.0. Total no. in groups: 20.0. Clinical observations: Erythema (well defined) - dryness and sloughing of the epidermis observed.
Reading:
1st reading
Hours after challenge:
48
Group:
test chemical
Dose level:
20% v/v in acetone
No. with + reactions:
1
Total no. in group:
20
Clinical observations:
Erythema (barely perceptible) - dryness and sloughing of the epidermis observed
Remarks on result:
other: see Remark
Remarks:
Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 20% v/v in acetone. No with. + reactions: 1.0. Total no. in groups: 20.0. Clinical observations: Erythema (barely perceptible) - dryness and sloughing of the epidermis observed.
Reading:
1st reading
Hours after challenge:
48
Group:
test chemical
Dose level:
20% v/v in acetone
No. with + reactions:
1
Total no. in group:
20
Clinical observations:
Oedema (barely perceptible)
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 20% v/v in acetone. No with. + reactions: 1.0. Total no. in groups: 20.0. Clinical observations: Oedema (barely perceptible).
Reading:
1st reading
Hours after challenge:
72
Group:
test chemical
Dose level:
50% v/v in acetone
No. with + reactions:
2
Total no. in group:
20
Clinical observations:
Erythema (barely perceptible) - dryness and sloughing of the epidermis observed
Remarks on result:
other: see Remark
Remarks:
Reading: 1st reading. . Hours after challenge: 72.0. Group: test group. Dose level: 50% v/v in acetone. No with. + reactions: 2.0. Total no. in groups: 20.0. Clinical observations: Erythema (barely perceptible) - dryness and sloughing of the epidermis observed.
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
50% v/v in acetone
No. with + reactions:
2
Total no. in group:
20
Clinical observations:
Erythema (barely perceptible)
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 50% v/v in acetone. No with. + reactions: 2.0. Total no. in groups: 20.0. Clinical observations: Erythema (barely perceptible).
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
50% v/v in acetone
No. with + reactions:
2
Total no. in group:
20
Clinical observations:
Erythema (barely perceptible) - localised dermal reaction
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 50% v/v in acetone. No with. + reactions: 2.0. Total no. in groups: 20.0. Clinical observations: Erythema (barely perceptible) - localised dermal reaction.
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
20% v/v in acetone
No. with + reactions:
2
Total no. in group:
20
Clinical observations:
Erythema (barely perceptible) - localised dermal reaction
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 20% v/v in acetone. No with. + reactions: 2.0. Total no. in groups: 20.0. Clinical observations: Erythema (barely perceptible) - localised dermal reaction.

Evidence of sensitisation of each challenge concentration:
Evidence of sensitisation was observed in 3 animals.

Interpretation of results:
other: not classified
Conclusions:
The test substance is not classified as a skin sensitiser. The study indicated that positive evidence of skin sensitisation was observed in 3 animals.
Executive summary:

Seaber (1986) is a skin sensitisation study following OECD guideline 406. The study is considered reliable without restriction and suitable for use for this endpoint.

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not sensitising)

Respiratory sensitisation

Endpoint conclusion
Endpoint conclusion:
no study available

Justification for classification or non-classification

The target substance is not sensitising to skin based on studies of structural analogue.